GAAP: the influence of restructuring fees, executive transition costs, convertible debt amortization and interest charges, business acquisition costs, litigation settlement fees, write-offs of deferred financing costs, non-cash long-lived asset impairment charges, losses on disposals of possessions related to restructuring activities, insurance demutualization gains, depreciation and amortization of buy accounting adjustments, nonrecurring income tax adjustments, and postretirement benefit plan settlement gains. June 30 Year to Day Total revenue for the six-month period ended, 2014 was $127.5 million, an increase of 7 percent in comparison to total revenue of $118.7 million for the same period in 2013. Total contract revenue for the first half a year of 2014 was $112.5 million, an increase of 16 percent in comparison to contract revenue of $97.3 million for the same period in 2013.Discussion In this study, apixaban, administered at a dose of 2.5 mg twice daily starting 12 to 24 hours after elective hip alternative and continued for 35 times, was more effective in preventing venous thromboembolism than was regular prophylaxis with the use of enoxaparin at a dose of 40 mg each day beginning the evening before surgical procedure. The apixaban regimen significantly reduced the complete threat of venous thromboembolism, including the important way of measuring major venous thromboembolism clinically. First-class efficacy was achieved without an increase in the risk of bleeding, since the proportion of sufferers with major or clinically relevant non-major bleeding was similar in the two organizations .